{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:50:12Z","timestamp":1792504212626,"version":"4.5.0"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>Lithium is a benchmark treatment for bipolar disorder in adults. Definitive studies of lithium in pediatric bipolar I disorder (BP-I) are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>This multicenter, randomized, double-blind, placebo-controlled study of pediatric participants (ages 7\u201317 years) with BP-I\/manic or mixed episodes compared lithium (n = 53) versus placebo (n = 28) for up to 8 weeks. The a priori primary efficacy measure was change from baseline to the end of study (week 8\/ET) in the Young Mania Rating Scale (YMRS) score, based on last-observation-carried-forward analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>The change in YMRS score was significantly larger in lithium-treated participants (5.51 [95% confidence interval: 0.51 to 10.50]) after adjustment for baseline YMRS score, age group, weight group, gender, and study site (P = .03). Overall Clinical Global Impression\u2013Improvement scores favored lithium (n = 25; 47% very much\/much improved) compared with placebo (n = 6; 21% very much\/much improved) at week 8\/ET (P = .03). A statistically significant increase in thyrotropin concentration was seen with lithium (3.0 \u00b1 3.1 mIU\/L) compared with placebo (\u20130.1 \u00b1 0.9 mIU\/L; P &amp;lt; .001). There was no statistically significant between-group difference with respect to weight gain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Lithium was superior to placebo in reducing manic symptoms in pediatric patients treated for BP-I in this clinical trial. Lithium was generally well tolerated in this patient population and was not associated with weight gain, distinguishing it from other agents commonly used to treat youth with bipolar disorder.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2015-0743","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T18:52:53Z","timestamp":1444762373000},"page":"885-894","source":"Crossref","is-referenced-by-count":120,"title":["Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study"],"prefix":"10.1542","volume":"136","author":[{"given":"Robert L.","family":"Findling","sequence":"first","affiliation":[{"name":"The Johns Hopkins University\/Kennedy Krieger Institute, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Robb","sequence":"additional","affiliation":[{"name":"Children's National Medical Center, George Washington University, Washington District of Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora K.","family":"McNamara","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani N.","family":"Pavuluri","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Kafantaris","sequence":"additional","affiliation":[{"name":"The Zucker Hillside Hospital and Feinstein Institute for Medical Research of the North Shore\u2013Long Island Jewish Health System, Manhasset, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Scheffer","sequence":"additional","affiliation":[{"name":"University of Kansas School of Medicine, Wichita, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean A.","family":"Frazier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Massachusetts Medical School\/UMASS Memorial Medical Center, Worcester, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Rynn","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute\/Columbia University, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"DelBello","sequence":"additional","affiliation":[{"name":"University of Cincinnati College of Medicine, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kowatch","sequence":"additional","affiliation":[{"name":"Wexner Medical Center\/Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brieana M.","family":"Rowles","sequence":"additional","affiliation":[{"name":"UPMC CancerCenter, Pittsburgh, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Lingler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Martz","sequence":"additional","affiliation":[{"name":"The EMMES Corporation, Rockville, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Anand","sequence":"additional","affiliation":[{"name":"The EMMES Corporation, Rockville, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci E.","family":"Clemons","sequence":"additional","affiliation":[{"name":"The EMMES Corporation, Rockville, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perdita","family":"Taylor-Zapata","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2015,11,1]]},"reference":[{"issue":"9","key":"2021120906114302200_B1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2004.01.022","article-title":"Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).","volume":"55","author":"Perlis","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"9","key":"2021120906114302200_B2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4088\/JCP.10m06290","article-title":"Meta-analysis of epidemiologic studies of pediatric bipolar disorder.","volume":"72","author":"Van Meter","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"2021120906114302200_B3"},{"issue":"2","key":"2021120906114302200_B4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.2012-0139","article-title":"Pediatric versus adult drug trials for conditions with high pediatric disease burden.","volume":"130","author":"Bourgeois","year":"2012","journal-title":"Pediatrics"},{"issue":"5","key":"2021120906114302200_B5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bdi.12094","article-title":"Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions.","volume":"15","author":"Hauser","year":"2013","journal-title":"Bipolar Disord"},{"issue":"11","key":"2021120906114302200_B6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archgenpsychiatry.2012.650","article-title":"Predictors of prospectively examined suicide attempts among youth with bipolar disorder.","volume":"69","author":"Goldstein","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"1\u20133","key":"2021120906114302200_B7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jad.2008.07.001","article-title":"Psychosocial functioning among bipolar youth.","volume":"114","author":"Goldstein","year":"2009","journal-title":"J Affect Disord"},{"issue":"10","key":"2021120906114302200_B8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.63.10.1139","article-title":"Phenomenology of children and adolescents with bipolar spectrum disorders.","volume":"63","author":"Axelson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2021120906114302200_B9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.wpsyc.2012.01.006","article-title":"Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients.","volume":"11","author":"Baldessarini","year":"2012","journal-title":"World Psychiatry"},{"issue":"10","key":"2021120906114302200_B10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement.","volume":"2","author":"Cade","year":"1949","journal-title":"Med J Aust"},{"issue":"2","key":"2021120906114302200_B11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.","volume":"161","author":"Geddes","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"8","key":"2021120906114302200_B12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/j.1440-1614.2005.01649.x","article-title":"Maintenance therapies in bipolar disorder: focus on randomized controlled trials.","volume":"39","author":"Muzina","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"issue":"8","key":"2021120906114302200_B13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1399-5618.2007.00445.x","article-title":"Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode.","volume":"9","author":"Storosum","year":"2007","journal-title":"Bipolar Disord"},{"issue":"9878","key":"2021120906114302200_B14","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder.","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"2021120906114302200_B15","first-page":"43","article-title":"Lithium","volume-title":"Treatment of Bipolar Disorder in Children and Adolescents","author":"Findling","year":"2008"},{"key":"2021120906114302200_B16","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development. Best Pharmaceuticals for Children Act. Available at: http:\/\/bpca.nichd.nih.gov. Accessed November 12, 2013"},{"issue":"4","key":"2021120906114302200_B17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/JCP.0b013e3181e66a62","article-title":"First-dose pharmacokinetics of lithium carbonate in children and adolescents.","volume":"30","author":"Findling","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"2021120906114302200_B18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/cap.2010.0084","article-title":"Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.","volume":"21","author":"Findling","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"2021120906114302200_B19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1753-2000-2-21","article-title":"The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation.","volume":"2","author":"Findling","year":"2008","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"2021120906114302200_B20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"issue":"7","key":"2021120906114302200_B21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"2021120906114302200_B22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004583-198403000-00011","article-title":"Preliminary studies of the reliability and validity of the children\u2019s depression rating scale.","volume":"23","author":"Poznanski","year":"1984","journal-title":"J Am Acad Child Psychiatry"},{"issue":"4","key":"2021120906114302200_B23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1207\/s15374424jccp2404_8","article-title":"Children\u2019s Depression Rating Scale-Revised: development of a short form.","volume":"24","author":"Overholser","year":"1995","journal-title":"J Clin Child Psychol"},{"issue":"2","key":"2021120906114302200_B24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S1092852900020678","article-title":"Factors in the assessment of suicidality in youth.","volume":"12","author":"Posner","year":"2007","journal-title":"CNS Spectr"},{"key":"2021120906114302200_B25","first-page":"839","article-title":"Clinical global impression scale.","volume":"21","author":"National Institute of Mental Health","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"2021120906114302200_B26","first-page":"501","article-title":"Clinical trials in children and adolescents","volume-title":"Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines","author":"Klein","year":"1994"},{"key":"2021120906114302200_B27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"11","key":"2021120906114302200_B28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A children\u2019s global assessment scale (CGAS).","volume":"40","author":"Shaffer","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"2021120906114302200_B29","volume-title":"Practical Meta-Analysis","author":"Lipsey","year":"2001"},{"issue":"5","key":"2021120906114302200_B30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archgenpsychiatry.2011.1508","article-title":"A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.","volume":"69","author":"Geller","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"2021120906114302200_B31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1176\/appi.ajp.2007.06111932","article-title":"Olanzapine versus placebo in the treatment of adolescents with bipolar mania.","volume":"164","author":"Tohen","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"10","key":"2021120906114302200_B32","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.","volume":"70","author":"Findling","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"2021120906114302200_B33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1399-5618.2009.00750.x","article-title":"Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.","volume":"11","author":"Haas","year":"2009","journal-title":"Bipolar Disord"},{"issue":"1","key":"2021120906114302200_B34","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.4088\/JCP.11m07424","article-title":"Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial.","volume":"74","author":"Pathak","year":"2013","journal-title":"J Clin Psychiatry"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/5\/885\/1094542\/peds_2015-0743.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/5\/885\/1094542\/peds_2015-0743.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:29:42Z","timestamp":1639096182000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/136\/5\/885\/33804\/Lithium-in-the-Acute-Treatment-of-Bipolar-I"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,1]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,11,1]]},"published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-0743","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,1]]}}}